Schmutterer I, Delcour J, Griebler RSchmutterer I, Delcour J. Frequency (Häufigkeit). In: Schmutterer I, Delcour J, Griebler R, editors. Austrian diabetes report 2017 (Österreichischer Diabetesbericht 2017). Vienna: Austria Federal Ministry of Health and Women’s Affairs (Bundesministerium für Gesundheit und Frauen; 2017. pp. 27–38.

Google Scholar 

International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium. 2021. https://www.diabetesatlas.org.

Stefano GB, Challenger S, Kream RM. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders. Eur J Nutr. 2016;55:2339–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paneni F, Lüscher TF. Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. Am J Cardiol. 2017;120(1S):S17–27.

Article  CAS  PubMed  Google Scholar 

Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, Deanfield J, Smeeth L, Timmis A, Hemingway H. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105–13.

Article  PubMed  PubMed Central  Google Scholar 

Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus: mechanisms, management, and clinical considerations. Circulation. 2016;133:2459–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kannel WB, McGee DL. Diabetes and cardiovascular disease. The framingham study. JAMA. 1979;241:2035–8.

Article  CAS  PubMed  Google Scholar 

Dunlay SM, Givertz MM, Aguilar D. Type 2 Diabetes Mellitus and Heart Failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019;140:e294-324.

Article  CAS  PubMed  Google Scholar 

Tang X, Zhu Y, Xing Z. Predicted lean body mass, fat mass, and heart failure in patients with type 2 diabetes mellitus. Am Heart J. 2023;257:78–84. https://doi.org/10.1016/j.ahj.2022.12.008.

Article  PubMed  Google Scholar 

Ohkuma T, Komorita Y, Peters SAE, Woodward M. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 2019;62:1550–60.

Article  PubMed  PubMed Central  Google Scholar 

McAllister DA, Read SH, Kerssens J, et al. Incidenceof hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus. Circulation. 2018;138:2774–86.

Article  PubMed  PubMed Central  Google Scholar 

AlGhatrif M, Strait JB, Morrell CH, Canepa M, Wright J, Elango P, Scuteri A, Najjar SS, Ferrucci L, Lakatta EG. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension. 2013;62(5):934–41.

Article  CAS  PubMed  Google Scholar 

Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008;105:1652–60. https://doi.org/10.1152/japplphysiol.90549.2008.

Article  PubMed  PubMed Central  Google Scholar 

MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ, CHARM Investigators. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:1377–85.

Article  PubMed  Google Scholar 

Hsich EM, Grau-Sepulveda MV, Hernandez AF, Eapen ZJ, Xian Y, Schwamm LH, Bhatt DL, Fonarow GC. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the get with the Guideline-Heart failure Registry. Am Heart J. 2013;166(6):1063–e10713.

Article  CAS  PubMed  Google Scholar 

Galvao M, Kalman J, DeMarco T, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry. J Card Fail. 2006. https://doi.org/10.1016/j.cardfail.2005.09.005.

Article  PubMed  Google Scholar 

Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996–1004.

Article  PubMed  PubMed Central  Google Scholar 

Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal Human Left and right ventricular dimensions for MRI as assessed by Turbo Gradient Echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003;17:323–9.

Article  PubMed  Google Scholar 

Salton CJ, Chuang ML, O’Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, Edelman RR, Levy D, Manning WJ. Gender differences and Normal Left Ventricular Anatomy in an adult Population Free of Hypertension. J Am Coll Cardiol. 2002;39:1055–60.

Article  PubMed  Google Scholar 

Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM, Canham RM, Levine BD, Drazner MH. Women have higher left ventricular ejection fractions than Men Independent of Differences in left ventricular volume: the Dallas Heart Study. Circulation. 2006;113:1597–604.

Article  PubMed  Google Scholar 

Petersen SE, Aung N, Sanghvi MM, Zemrak F, Fung K, Paiva JM, Francis JM, Khanji MY, Lukaschuk E, Lee AM, et al. Reference ranges for Cardiac structure and function using Cardiovascular magnetic resonance (CMR) in caucasians from the UK Biobank Population Cohort. J Cardiovasc Magn Reson. 2017;19:18.

Article  PubMed  PubMed Central  Google Scholar 

Oparil S, Miller AP. Gender and blood pressure. J Clin Hypertens (Greenwich). 2005;7:300–9.

Article  PubMed  Google Scholar 

Karpanou EA. ABP changes in menstrual cycle of hypertensive women: data reworked. Am J Hypertens. 1995;6:656.

Article  Google Scholar 

Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol. 1974;34:29–34.

Article  CAS  PubMed  Google Scholar 

Peters SAE, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57:1542–51.

Article  PubMed  Google Scholar 

Ohkuma T, Komorita Y, Peters SAE, Woodward M. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 2019;62:1550–60. https://doi.org/10.1007/s00125-019-4926-x.

Article  PubMed  PubMed Central  Google Scholar 

Nieminen MS, Harjola VP, Hochadel M, et al. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart failure survey II. Eur J Heart Fail. 2008;10:140–8.

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 2022;75(6):523. English, Spanish.

PubMed  Google Scholar 

Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, Morrow DA, Drazner MH, McGuire DK, de Lemos JA. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol. 2005;96(9):1284–9.

Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976–82.

Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, Levy D. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA. 2002;288(10):1252–9.

Christ M, Laule-Kilian K, Hochholzer W, et al. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol. 2006;48:1808–12.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726.

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of Heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation. 2022;145:e895–1032.

Prausmüller S, Resl M, Arfsten H, Spinka G, Wurm R, Neuhold S, Bartko PE, Goliasch G, Strunk G, Pavo N, Clodi M, Hülsmann M. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):34.

Article  PubMed  PubMed Central